BIOMAT Database Logo BIOMAT Database Logo

Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits. 1987

T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
July 1986, Chemical & pharmaceutical bulletin,
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
August 1983, Chemical & pharmaceutical bulletin,
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
[Preparation of capsules of microencapsulated indomethacin and their bioavailability in rabbits].
December 1986, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
Studies on sustained-release dosage forms. III. Preparation of nifedipine suppositories and bioavailability in rabbits.
September 1985, Chemical & pharmaceutical bulletin,
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
Sustained release indomethacin: a double blind comparison with indomethacin suppositories.
April 1981, The New Zealand medical journal,
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
Studies on sustained-release dosage forms. II. Pharmacokinetics after rectal administration of indomethacin suppositories in rabbits.
September 1983, Chemical & pharmaceutical bulletin,
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
[Studies on the bioavailability of sustained-release indomethacin capsules].
May 1985, Yao xue xue bao = Acta pharmaceutica Sinica,
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
[Bioavailability of metoclopramide in a sustained-release preparation].
January 1984, Arzneimittel-Forschung,
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
[Clinical evaluation of sustained-release preparation of indomethacin].
November 1972, Ryumachi. [Rheumatism],
T Nakajima, and Y Takashima, and K Iida, and H Mitsuta, and A Furuya, and M Koishi
Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions.
August 1987, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!